EW
Edwards Lifesciences Corporation Healthcare - Medical Devices Investor Relations →
Edwards Lifesciences Corporation (EW) closed at $82.50 as of 2026-03-20, trading 3.2% above its 200-week moving average of $79.95. The stock moved further from the line this week, up from 2.2% last week. The 14-week RSI sits at 49, indicating neutral momentum.
Trading volume is running at 1.2x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.98 ratio) is neutral — neither side is clearly dominating.
Over the past 1307 weeks of data, EW has crossed below its 200-week moving average 11 times. On average, these episodes lasted 19 weeks. Historically, investors who bought EW at the start of these episodes saw an average one-year return of +23.3%.
With a market cap of $47.9 billion, EW is a large-cap stock. The company generates a free cash flow yield of 2.4%. Return on equity stands at 10.4%. The stock trades at 4.6x book value.
Over the past 25.1 years, a hypothetical investment of $100 in EW would have grown to $5051, compared to $876 for the S&P 500. That represents an annualized return of 16.9% vs 9.0% for the index — confirming EW as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: EW vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After EW Crosses Below the Line?
Across 10 historical episodes, buying EW when it crossed below its 200-week moving average produced an average return of +19.6% after 12 months (median +28.0%), compared to +6.2% for the S&P 500 over the same periods. 70% of those episodes were profitable after one year. After 24 months, the average return was +55.9% vs +16.2% for the index.
Each line shows $100 invested at the moment EW crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
EW has crossed below its 200-week MA 11 times with an average 1-year return of +23.3% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 2001 | Mar 2001 | 1 | 5.5% | +55.3% | +5461.8% |
| Apr 2001 | Apr 2001 | 1 | 2.0% | +50.8% | +5257.1% |
| Jul 2002 | Jul 2002 | 3 | 9.1% | +47.2% | +4441.3% |
| Feb 2008 | Mar 2008 | 5 | 2.4% | +47.1% | +2213.6% |
| Apr 2013 | Oct 2013 | 25 | 10.5% | +25.4% | +671.4% |
| Oct 2013 | Apr 2014 | 24 | 18.7% | +88.1% | +670.2% |
| Sep 2022 | Jun 2023 | 38 | 20.6% | -17.8% | -2.6% |
| Jul 2023 | Mar 2024 | 32 | 31.1% | -25.5% | -1.5% |
| Apr 2024 | Jun 2024 | 11 | 6.1% | -23.1% | -8.6% |
| Jul 2024 | Nov 2025 | 69 | 33.3% | -14.2% | -9.3% |
| Feb 2026 | Feb 2026 | 3 | 5.7% | N/A | +4.8% |
| Average | 19 | — | +23.3% | — |
Frequently Asked Questions
Is EW below its 200-week moving average?
No. Edwards Lifesciences Corporation (EW) is currently 3.2% above its 200-week moving average of $79.95. It would need to fall to $79.95 to cross below the line.
What is EW's 200-week moving average price?
Edwards Lifesciences Corporation's 200-week moving average is $79.95 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when EW drops below its 200-week moving average?
EW has crossed below its 200-week moving average 11 times in our data. On average, buying at that moment produced a one-year return of +23.3%. These dips have historically been decent entry points. These episodes lasted 19 weeks on average.
Is EW a good value right now?
Here's what our data says about EW as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 49. Free cash flow yield is 2.4%. Return on equity is 10.4%. Price-to-book is 4.6x. This is not a buy or sell recommendation — always do your own research.
How does EW compare to the S&P 500?
Over the past 25.1 years, $100 invested in EW would have grown to $5051, compared to $876 for the S&P 500. That's 16.9% annualized vs 9.0% for the index. EW has outperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20